Abstract:Background: Limbal stem cell deficiency (LSCD) is a refractory ocular surface disorder characterized by progressive corneal epithelial degeneration, conjunctivalization, and neovascularization, potentially leading to blindness. There are currently no effective therapeutic options for patients experiencing routine symptomatic treatment failure. Transplantation of amniotic membrane (AM) with adherent stem cells (but not bare AM transplantation alone) has shown promise in preclinical studies for ocular surface restoration. A major limitation, however, is finding a reliable stem cell source. Stem cells can be isolated from the peripheral blood mononuclear cell (PBMC) population, and these PBMC-derived stem cells have numerous advantages over allogeneic and other autologous stem cell types for therapeutic application, including relative ease of acquisition, nonimmunogenicity, and the absence of ethical issues associated with embryonic stem cells. Experiment: We examined the efficacy of autologous PBMC-AM sheet cultures combined with postoperative antiangiogenesis treatment for corneal restoration in LSCD model rabbits. Rabbit PBMCs (rPBMCs) were isolated, labeled with EdU for in vivo tracing, and then cultured on AMs in conditioned medium before transplantation. Rabbits were transplanted with bare AMs (group 1), rPBMC-AM sheets (group 2), or rPBMC-AM sheets plus postoperative treatment with the vascular endothelial growth factor antagonist bevacizumab (group 3). Corneal opacity and neovascularization were monitored by slit-lamp imaging for 8 weeks and corneas were examined histologically at 1 and 2 months. Results: Corneal opacity decreased in all three groups over 8 weeks, but was significantly lower in group 2 and even lower in group 3. Corneal neovascularization was significantly higher in group 1 throughout the observation period, and significantly lower in group 3 than group 1 and 2 by 8 weeks post-transplant. At 4 weeks, the corneal surface completed epithelialization (although thinner than normal) in group 3 but still patchy in groups 1 and 2. By 8 weeks, the epithelium in group 3 was complete and smooth, resembling a normal epithelium. Integrin β1 as a progenitor marker was also generally higher in groups 2 and 3. Conclusions: Autologous rPBMC-AM sheets with post-transplant topical bevacizumab can effectively facilitate corneal epithelium recovery in a LSCD model, suggesting clinical utility for LSCD-related ocular surface diseases. Impact statement Limbal stem cell deficiency (LSCD) increases corneal opacity and vascularization, resulting in severe visual impairment or even blindness. Traditional surgical limbal transplant is currently the main treatment option for LSCD, but carries the risks of rejection and immunosuppressant side effects. Autologous stem cell-based therapy is a promising alternative approach, but a reliable stem cell source is a major limitation. We report that transplantation of autologous rabbit peripheral blood mononuclear cell-amniotic membrane sheets plus antivascular endothelial growth factor restored avascular transparent cornea in a rabbit LSCD model. These results demonstrate a potentially effective approach for ocular surface reconstruction in bilateral LSCD.

Reconstruction of Damaged Corneal Epithelium Using Venus-labeled Limbal Epithelial Stem Cells and Tracking of Surviving Donor Cells

[Establishment of Goat Limbal Stem Cell Strain Expressing Venus Fluorescent Protein and Construction of Limbal Epithelial Sheets].

Reconstruction of Corneal Epithelium with Cryopreserved Corneal Limbal Stem Cells in a Goat Model

Reconstruction of Damaged Cornea by Autologous Transplantation of Epidermal Adult Stem Cells

Reconstruction of corneal epithelium with cryopreserved corneal limbal stem cells in a rabbit model.

Corneal Reconstruction with EGFP-Labelled Limbal Mesenchymal Stem Cells in a Rabbit Model of Limbal Stem Cell Deficiency

Ocular surface reconstruction with suspended limbal stem cells delivered by sutureless fixated amniotic membrane patch

Reconstruction of Corneal Surface Layer Using Human Amniotic Epithelial Cells Modified by Lentiviral Vector-Mediated EGFP Gene

Reconstruction of Functional Ocular Surface by Acellular Porcine Cornea Matrix Scaffold and Limbal Stem Cells Derived from Human Embryonic Stem Cells.

Corneal Recovery Following Rabbit Peripheral Blood Mononuclear Cell-Amniotic Membrane Transplantation with Antivascular Endothelial Growth Factor in Limbal Stem Cell Deficiency Rabbits

Corneal Epithelial Changes Following Reconstruction by Transplantation of Limbal Stem Cells in Goats with Total Limbal Stem Cell Deficiency

3D Bioprinting As a Prospective Therapeutic Strategy for Corneal Limbal Epithelial Stem Cell Deficiency

Regeneration of corneal epithelium utilizing a collagen vitrigel membrane in rabbit models for corneal stromal wound and limbal stem cell deficiency

Transplantation of Tissue-Engineered Human Corneal Epithelium in Limbal Stem Cell Deficiency Rabbit Models.

Construction of corneal epithelium with human amniotic epithelial cells and repair of limbal deficiency in rabbit models

Transplantation of Human Limbal Cells Cultivated on Amniotic Membrane for Reconstruction of Rat Corneal Epithelium after Alkaline Burn

Limbal epithelial stem cells in corneal surface reconstruction

Co-transplantation of Limbal Epithelial and Stromal Cells for Ocular Surface Reconstruction

Decoding cellular plasticity and niche regulation of limbal stem cells during corneal wound healing

Reconstruction of Highly Proliferative Auto-Tissue-Engineered Lamellar Cornea Enhanced by Embryonic Stem Cell.

Reconstruction of the Ocular Surface by Autologous Transplantation of Rabbit Adipose Tissue-Derived Stem Cells on Amniotic Membrane